Pavlovian Conditioned Approach, Goal-tracking, average magazine entry number on day 2 of testing
Project: p50_paul_meyer_2014
0 significantly associated models · 0 unique genes
| tissue | modality | # hits | % hits/tests | avg chisq |
|---|---|---|---|---|
| Adipose | alternative polyA | 0 | 0 | 1.13 |
| Adipose | alternative TSS | 0 | 0 | 1.15 |
| Adipose | gene expression | 0 | 0 | 1.11 |
| Adipose | isoform ratio | 0 | 0 | 1.07 |
| Adipose | intron excision ratio | 0 | 0 | 1.17 |
| Adipose | mRNA stability | 0 | 0 | 1.13 |
| BLA | alternative polyA | 0 | 0 | 1.15 |
| BLA | alternative TSS | 0 | 0 | 1.03 |
| BLA | gene expression | 0 | 0 | 1.14 |
| BLA | isoform ratio | 0 | 0 | 1.02 |
| BLA | intron excision ratio | 0 | 0 | 1.13 |
| BLA | mRNA stability | 0 | 0 | 1.17 |
| Brain | alternative polyA | 0 | 0 | 1.27 |
| Brain | alternative TSS | 0 | 0 | 1.04 |
| Brain | gene expression | 0 | 0 | 1.10 |
| Brain | isoform ratio | 0 | 0 | 1.16 |
| Brain | intron excision ratio | 0 | 0 | 1.16 |
| Brain | mRNA stability | 0 | 0 | 1.13 |
| Eye | alternative polyA | 0 | 0 | 1.15 |
| Eye | alternative TSS | 0 | 0 | 0.87 |
| Eye | gene expression | 0 | 0 | 1.15 |
| Eye | isoform ratio | 0 | 0 | 1.15 |
| Eye | intron excision ratio | 0 | 0 | 1.15 |
| Eye | mRNA stability | 0 | 0 | 0.89 |
| IL | alternative polyA | 0 | 0 | 1.29 |
| IL | alternative TSS | 0 | 0 | 1.18 |
| IL | gene expression | 0 | 0 | 1.12 |
| IL | isoform ratio | 0 | 0 | 1.15 |
| IL | intron excision ratio | 0 | 0 | 1.15 |
| IL | mRNA stability | 0 | 0 | 1.23 |
| LHb | alternative polyA | 0 | 0 | 1.26 |
| LHb | alternative TSS | 0 | 0 | 1.23 |
| LHb | gene expression | 0 | 0 | 1.13 |
| LHb | isoform ratio | 0 | 0 | 1.21 |
| LHb | intron excision ratio | 0 | 0 | 1.19 |
| LHb | mRNA stability | 0 | 0 | 1.23 |
| Liver | alternative polyA | 0 | 0 | 1.13 |
| Liver | alternative TSS | 0 | 0 | 1.16 |
| Liver | gene expression | 0 | 0 | 1.13 |
| Liver | isoform ratio | 0 | 0 | 1.11 |
| Liver | intron excision ratio | 0 | 0 | 1.20 |
| Liver | mRNA stability | 0 | 0 | 1.12 |
| NAcc | alternative polyA | 0 | 0 | 1.18 |
| NAcc | alternative TSS | 0 | 0 | 1.01 |
| NAcc | gene expression | 0 | 0 | 1.11 |
| NAcc | isoform ratio | 0 | 0 | 1.20 |
| NAcc | intron excision ratio | 0 | 0 | 1.24 |
| NAcc | mRNA stability | 0 | 0 | 1.25 |
| NAcc2 | alternative polyA | 0 | 0 | 1.16 |
| NAcc2 | alternative TSS | 0 | 0 | 1.00 |
| NAcc2 | gene expression | 0 | 0 | 1.16 |
| NAcc2 | isoform ratio | 0 | 0 | 1.14 |
| NAcc2 | intron excision ratio | 0 | 0 | 1.19 |
| NAcc2 | mRNA stability | 0 | 0 | 1.13 |
| OFC | alternative polyA | 0 | 0 | 1.15 |
| OFC | alternative TSS | 0 | 0 | 1.01 |
| OFC | gene expression | 0 | 0 | 1.10 |
| OFC | isoform ratio | 0 | 0 | 1.13 |
| OFC | intron excision ratio | 0 | 0 | 1.18 |
| OFC | mRNA stability | 0 | 0 | 1.20 |
| PL | alternative polyA | 0 | 0 | 1.29 |
| PL | alternative TSS | 0 | 0 | 1.29 |
| PL | gene expression | 0 | 0 | 1.14 |
| PL | isoform ratio | 0 | 0 | 1.18 |
| PL | intron excision ratio | 0 | 0 | 1.21 |
| PL | mRNA stability | 0 | 0 | 1.20 |
| PL2 | alternative polyA | 0 | 0 | 1.22 |
| PL2 | alternative TSS | 0 | 0 | 0.93 |
| PL2 | gene expression | 0 | 0 | 1.13 |
| PL2 | isoform ratio | 0 | 0 | 1.07 |
| PL2 | intron excision ratio | 0 | 0 | 1.14 |
| PL2 | mRNA stability | 0 | 0 | 1.18 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.